FRAXIN
FRAXIN Basic information
- Product Name:
- FRAXIN
- Synonyms:
-
- Fraxetol8-glucoside
- 7,8-Dihydroxy-6-methoxycoumarin 8-β-D-glucopyranoside
- Fraxetin 8-β-D-glucopyranoside
- 8-(β-D-Glucopyranosyloxy)-7-hydroxy-6-methoxycoumarin monohydrate
- 7,8-DIHYDROXY-6-METHOXYCOUMARIN-BETA-D-GLUCOPYRANOSIDE
- FRAXETIN-8-GLUCOSIDE
- FRAXETIN-8-O-GLUCOSIDE
- FRAXIN
- CAS:
- 524-30-1
- MF:
- C16H18O10
- MW:
- 370.31
- EINECS:
- 208-355-5
- Product Categories:
-
- chemical reagent
- pharmaceutical intermediate
- phytochemical
- reference standards from Chinese medicinal herbs (TCM).
- standardized herbal extract
- Coumarins
- Mol File:
- 524-30-1.mol
FRAXIN Chemical Properties
- Melting point:
- 205-208°C
- Boiling point:
- 420.23°C (rough estimate)
- Density
- 1.4066 (rough estimate)
- refractive index
- 1.5376 (estimate)
- storage temp.
- Sealed in dry,Room Temperature
- solubility
- DMSO : 250 mg/mL (675.11 mM; Need ultrasonic)
- form
- Solid
- pka
- 6.99±0.20(Predicted)
- color
- White
- InChI
- InChI=1/C16H18O10/c1-23-7-4-6-2-3-9(18)25-14(6)15(11(7)20)26-16-13(22)12(21)10(19)8(5-17)24-16/h2-4,8,10,12-13,16-17,19-22H,5H2,1H3/t8-,10-,12+,13-,16+/s3
- InChIKey
- CRSFLLTWRCYNNX-JAAAIXMONA-N
- SMILES
- C12OC(=O)C=CC=1C=C(OC)C(O)=C2O[C@H]1[C@H](O)[C@H]([C@H](O)[C@@H](CO)O1)O |&1:15,16,18,19,21,r|
- LogP
- -1.930 (est)
FRAXIN Usage And Synthesis
Chemical Properties
Slightly soluble in cold water, soluble in hot water and hot ethanol, practically insoluble in ether. Derived from the dried bark of the ash tree of the family Mulleinaceae, the pointed leaf ash or the persistent column ash
Uses
food and beverages
Definition
ChEBI: Fraxin is a beta-D-glucoside that is fraxetin attached to a beta-D-glucopyranosyl group at position 8 via a glycosidic linkage. It is a natural product isolated from the leaves of Fraxinus excelsior and exhibits potent hepatoprotective effects in vitro and in vivo. It has a role as a plant metabolite, an anti-inflammatory agent and a hepatoprotective agent. It is a beta-D-glucoside, a hydroxycoumarin and an aromatic ether. It is functionally related to a fraxetin.
in vivo
Fraxin (50 mg/kg, p.o.) significantly blocks the CCl4-induced elevation of ALT and AST. Fraxin (10 and 50 mg/kg, p.o.) significantly reduces the GSSG levels (1.7±0.3 and 1.5±0.2 nM/g liver, respectively) compared with the GSSG levels of the CCl4-treated group[1].
FRAXINSupplier
- Tel
- 025-025-51191215 18013836722
- 2399235533@qq.com
- Tel
- 18805194892
- 2727751293@qq.com
- Tel
- +86-21-20908456
- sales@BioChemBest.com
- Tel
- 4009903999 13355009207
- 3007715519@qq.com
- Tel
- 400-1166-196 18981987031
- cdhxsj@163.com
FRAXIN(524-30-1)Related Product Information
- 2-Methoxyhydroquinone
- 2,3-DIMETHOXYTOLUENE
- METHYL BETA-D-GLUCOPYRANOSIDE
- FRAXIN
- 2-(Allyloxy)phenol
- 2-(3-METHYLPHENOXY)ETHANOL
- 2-(2-HYDROXYETHOXY)PHENOL
- 3-Phenoxy-1,2-propanediol
- 3,4-Dimethoxyphenol
- 2-ETHOXY-4-METHYLPHENOL
- 6-Hydroxycoumarin
- 2-Ethoxyphenol
- 2-METHOXYPHENYL ACETATE
- Guaifenesin
- 3-Butoxyphenol
- Isofraxidin
- METHYL BETA-D-GLUCOPYRANOSIDE HEMIHYDRATE
- 1,2,4-Benzenetriol